5-N-Acetylardeemin, A Novel Heterocyclic Compound which Reverses Multiple Drug Resistance in Tumor Cells: II. Isolation and Elucidation of the Structure of 5-N-Acetylardeemin and Two Congeners

113Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

A family of novel compounds has been detected and isolated following an assay for the attenuation of multiple drug resistance in tumor cells from the fermentation broth and mycelia of a strain of Aspergillus fischeri which we have designated var. brasiliensis. The structures of three components were determined employing 1-D and 2-D homonuclear and heteronuclear NMR spectroscopy and mass spectrometry. The structure of 5-N-acetylardeemin was confirmed by single crystal X-ray diffraction. These compounds are most closely structurally related to asnerlicin E1). © 1993, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Hochlowski, J. E., Mullally, M. M., Phanton, S. G., Whittern, D. N., Hill, P., & McAlpine, J. B. (1993). 5-N-Acetylardeemin, A Novel Heterocyclic Compound which Reverses Multiple Drug Resistance in Tumor Cells: II. Isolation and Elucidation of the Structure of 5-N-Acetylardeemin and Two Congeners. Journal of Antibiotics, 46(3), 380–386. https://doi.org/10.7164/antibiotics.46.380

Readers over time

‘15‘16‘21‘2201234

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

75%

Researcher 1

25%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 2

50%

Chemistry 2

50%

Save time finding and organizing research with Mendeley

Sign up for free
0